126 related articles for article (PubMed ID: 35296570)
1. Clinicopathological Role of Vasohibin in Gastroenterological Cancers: A Meta-Analysis.
Yamamoto M; Ozawa S; Koyanagi K; Ninomiya Y; Hara H; Kazuno A; Yatabe K; Higuchi T; Nakamura K; Nabeshima K; Sato Y
Tohoku J Exp Med; 2022 Apr; 256(4):291-301. PubMed ID: 35296570
[TBL] [Abstract][Full Text] [Related]
2. Plasma vasohibin-1 and vasohibin-2 are useful biomarkers in patients with esophageal squamous cell carcinoma.
Yamamoto M; Ozawa S; Ninomiya Y; Koyanagi K; Oguma J; Kazuno A; Hara H; Yatabe K; Kajiwara H; Nakamura N; Sato Y
Esophagus; 2020 Jul; 17(3):289-297. PubMed ID: 31980976
[TBL] [Abstract][Full Text] [Related]
3. Expression of vasohibin-1 and -2 predicts poor prognosis among patients with squamous cell carcinoma of the esophagus.
Ninomiya Y; Ozawa S; Oguma J; Kazuno A; Nitta M; Kajiwara H; Sato Y
Oncol Lett; 2018 Oct; 16(4):5265-5274. PubMed ID: 30250596
[TBL] [Abstract][Full Text] [Related]
4. Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation.
Suenaga K; Kitahara S; Suzuki Y; Kobayashi M; Horie S; Sugawara J; Yaegashi N; Sato Y
PLoS One; 2014; 9(9):e104728. PubMed ID: 25184477
[TBL] [Abstract][Full Text] [Related]
5. Vasohibin-1 and -2 in pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors.
Inoue C; Miki Y; Saito-Koyama R; Kobayashi K; Seyama K; Okada Y; Sasano H
Pathol Res Pract; 2022 Feb; 230():153758. PubMed ID: 35026646
[TBL] [Abstract][Full Text] [Related]
6. Significance of vasohibin 1 in cancer patients: A systematic review and meta analysis.
Liu S; Han B; Sun M; Wang J; Sun Y; Wang Y
J Cancer Res Ther; 2022 Apr; 18(2):567-575. PubMed ID: 35645129
[TBL] [Abstract][Full Text] [Related]
7. The vasohibin family: Novel regulators of angiogenesis.
Sato Y
Vascul Pharmacol; 2012; 56(5-6):262-6. PubMed ID: 22286022
[TBL] [Abstract][Full Text] [Related]
8. The vasohibin family: a novel family for angiogenesis regulation.
Sato Y
J Biochem; 2013 Jan; 153(1):5-11. PubMed ID: 23100270
[TBL] [Abstract][Full Text] [Related]
9. Depletion of Vasohibin 1 Speeds Contraction and Relaxation in Failing Human Cardiomyocytes.
Chen CY; Salomon AK; Caporizzo MA; Curry S; Kelly NA; Bedi K; Bogush AI; Krämer E; Schlossarek S; Janiak P; Moutin MJ; Carrier L; Margulies KB; Prosser BL
Circ Res; 2020 Jul; 127(2):e14-e27. PubMed ID: 32272864
[TBL] [Abstract][Full Text] [Related]
10. Requisite role of vasohibin-2 in spontaneous gastric cancer formation and accumulation of cancer-associated fibroblasts.
Suzuki Y; Kitahara S; Suematsu T; Oshima M; Sato Y
Cancer Sci; 2017 Dec; 108(12):2342-2351. PubMed ID: 28960674
[TBL] [Abstract][Full Text] [Related]
11. Development of a Novel and Simple Anti-Metastatic Cancer Treatment Targeting Vasohibin-2.
Lee ES; Suzuki Y; Tomioka H; Nakagami H; Sato Y
Tohoku J Exp Med; 2023 Nov; 261(3):239-247. PubMed ID: 37704418
[TBL] [Abstract][Full Text] [Related]
12. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
[TBL] [Abstract][Full Text] [Related]
13. VASH1-SVBP and VASH2-SVBP generate different detyrosination profiles on microtubules.
Ramirez-Rios S; Choi SR; Sanyal C; Blum TB; Bosc C; Krichen F; Denarier E; Soleilhac JM; Blot B; Janke C; Stoppin-Mellet V; Magiera MM; Arnal I; Steinmetz MO; Moutin MJ
J Cell Biol; 2023 Feb; 222(2):. PubMed ID: 36512346
[TBL] [Abstract][Full Text] [Related]
14. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
[TBL] [Abstract][Full Text] [Related]
15. Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment.
Koyanagi T; Suzuki Y; Komori K; Saga Y; Matsubara S; Fujiwara H; Sato Y
Cancer Sci; 2017 Mar; 108(3):512-519. PubMed ID: 28032401
[TBL] [Abstract][Full Text] [Related]
16. Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.
Zhang T; Yu TT; Zhang DM; Hou XM; Liu XJ; Zhao D; Shan L
Med Oncol; 2014 May; 31(5):963. PubMed ID: 24748406
[TBL] [Abstract][Full Text] [Related]
17. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
[TBL] [Abstract][Full Text] [Related]
18. Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.
Kitajima T; Toiyama Y; Tanaka K; Saigusa S; Kobayashi M; Inoue Y; Mohri Y; Kusunoki M
Anticancer Res; 2014 Oct; 34(10):5321-9. PubMed ID: 25275025
[TBL] [Abstract][Full Text] [Related]
19. Knockout of vasohibin-2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer.
Koyanagi T; Saga Y; Takahashi Y; Tamura K; Yoshiba T; Takahashi S; Taneichi A; Takei Y; Urabe M; Mizukami H; Fujiwara H
Cancer Med; 2021 Apr; 10(8):2732-2739. PubMed ID: 33710778
[TBL] [Abstract][Full Text] [Related]
20. Pathological Study on the Expression of Vasohibins in Peripheral Artery Disease.
Isoda R; Morita I; Ishida A; Mikami Y; Monobe Y; Sato Y; Moriya T
Tohoku J Exp Med; 2022 Sep; 258(2):121-128. PubMed ID: 35922907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
